PMC17 MONITORING OF PHARMACEUTICAL COST OF REIMBURSED MEDICINES BY COMBINING OFFICIAL PHARMACY INVOICE DATA WITH COMMERCIAL IMS SALES DATA
Nov 1, 2006, 00:00 AM
10.1016/S1098-3015(10)63429-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)63429-8/fulltext
Section Title :
Section Order :
281
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63429-8&doi=10.1016/S1098-3015(10)63429-8